HOME
PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Mobile
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
John C Byrd Selected Research
John C Byrd Research Topics
Disease
123
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2015 - 02/2002
78
Neoplasms (Cancer)
09/2015 - 02/2002
35
Leukemia
09/2015 - 02/2002
29
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2015 - 01/2004
17
Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2015 - 02/2002
17
Lymphoma (Lymphomas)
04/2015 - 08/2003
11
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 01/2009
8
Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 09/2003
8
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2014 - 05/2005
8
Multiple Myeloma
02/2014 - 05/2008
7
Infection
01/2015 - 04/2002
7
Tumor Lysis Syndrome
12/2014 - 08/2003
7
Chromosome Aberrations (Chromosome Abnormalities)
12/2014 - 01/2003
7
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2013 - 04/2008
6
Graft vs Host Disease (Graft-Versus-Host Disease)
11/2014 - 04/2005
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2013 - 09/2007
5
Diarrhea
07/2014 - 05/2010
5
Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2012 - 04/2008
5
B-Cell Lymphoma (Lymphoma, B Cell)
03/2009 - 08/2003
4
Neutropenia
12/2014 - 05/2010
4
Fatigue
07/2014 - 05/2010
4
Fever (Fevers)
07/2014 - 09/2002
4
Residual Neoplasm
03/2014 - 03/2004
3
Agammaglobulinemia (Hypogammaglobulinemia)
07/2015 - 04/2002
3
Thrombocytopenia (Thrombopenia)
12/2014 - 04/2010
3
Nausea
07/2014 - 05/2010
3
Lymphatic Diseases (Lymphadenopathy)
05/2014 - 01/2009
3
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2013 - 02/2004
3
Disease Progression
03/2010 - 08/2004
2
Opportunistic Infections (Opportunistic Infection)
04/2015 - 12/2005
2
Hairy Cell Leukemia
01/2015 - 03/2012
2
Breast Neoplasms (Breast Cancer)
01/2015 - 05/2013
2
Burkitt Lymphoma (Burkitt's Lymphoma)
10/2013 - 06/2011
Drug/Important Bio-Agent (IBA)
37
rituximab (Mabthera)
FDA Link
01/2015 - 02/2002
27
fludarabine
IBA
11/2015 - 02/2002
27
flavopiridol
IBA
05/2015 - 06/2005
15
Phosphotransferases (Kinase)
IBA
02/2015 - 05/2005
13
lenalidomide (CC 5013)
FDA Link
04/2015 - 05/2008
10
Histones (Histone)
IBA
04/2015 - 07/2003
9
Cyclophosphamide (Cytoxan)
FDA Link
Generic
11/2015 - 12/2005
9
Cyclins
IBA
02/2015 - 01/2007
8
fingolimod (FTY720)
FDA Link
09/2015 - 09/2007
8
Immunoglobulins (Immunoglobulin)
IBA
04/2015 - 02/2004
8
Pentostatin (Nipent)
FDA Link
Generic
01/2015 - 04/2005
8
bortezomib (Velcade)
FDA Link
06/2014 - 09/2006
8
alemtuzumab (Campath)
FDA Link
12/2013 - 07/2003
8
DNA (Deoxyribonucleic Acid)
IBA
01/2013 - 02/2005
8
decitabine (5-aza-2'-deoxycytidine)
FDA Link
01/2013 - 07/2005
7
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
09/2015 - 06/2011
7
Antibodies
IBA
06/2015 - 08/2007
7
Antigens
IBA
02/2014 - 09/2003
6
Cytarabine (Cytosar-U)
FDA Link
Generic
06/2015 - 01/2003
6
imatinib (Gleevec)
FDA Link
12/2014 - 05/2005
5
MicroRNAs (MicroRNA)
IBA
09/2015 - 06/2009
5
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
07/2014 - 08/2004
5
Proteins (Proteins, Gene)
IBA
05/2013 - 01/2003
4
milatuzumab
IBA
06/2015 - 04/2011
4
RNA (Ribonucleic Acid)
IBA
04/2015 - 06/2009
4
Agammaglobulinaemia tyrosine kinase (Bruton's tyrosine kinase)
IBA
01/2015 - 02/2014
4
Phosphatidylinositols (Phosphatidylinositol)
IBA
05/2014 - 01/2009
4
Interleukin-2 (IL2)
IBA
01/2010 - 09/2004
4
Histone Deacetylases (Histone Deacetylase)
IBA
02/2005 - 07/2003
3
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2015 - 01/2009
3
ofatumumab
FDA Link
08/2015 - 03/2013
3
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
06/2015 - 06/2008
3
GTI2040
IBA
06/2015 - 06/2008
3
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
12/2014 - 09/2010
3
Cyclin D1
IBA
02/2014 - 06/2010
3
Oligonucleotides
IBA
01/2013 - 06/2009
3
death-associated protein kinase
IBA
01/2013 - 06/2007
3
silvestrol
IBA
01/2013 - 05/2009
3
interleukin-21 (interleukin 21)
IBA
10/2012 - 05/2008
3
Immunoglobulin G (IgG)
IBA
04/2012 - 02/2004
3
Protein Kinases (Protein Kinase)
IBA
06/2011 - 09/2006
3
Monoclonal Antibodies
IBA
11/2010 - 07/2003
3
NF-kappa B (NF-kB)
IBA
07/2010 - 02/2008
3
oblimersen (G3139)
IBA
01/2010 - 01/2003
3
Messenger RNA (mRNA)
IBA
01/2010 - 08/2007
3
Complement System Proteins (Complement)
IBA
01/2008 - 02/2002
2
carfilzomib
IBA
10/2015 - 05/2013
2
Oligodeoxyribonucleotides
IBA
06/2015 - 02/2010
2
monoclonal antibody IMMU-106
IBA
06/2015 - 04/2012
2
Biological Markers (Surrogate Marker)
IBA
05/2015 - 01/2010
2
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
12/2014 - 05/2014
2
Nucleotides
IBA
07/2014 - 01/2008
2
Chromatin
IBA
03/2014 - 01/2011
2
Small Interfering RNA (siRNA)
IBA
11/2013 - 04/2007
2
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
09/2013 - 01/2013
2
Transferrin (beta 2 Transferrin)
IBA
05/2013 - 02/2010
2
Liposomes (Liposome)
IBA
01/2013 - 04/2008
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2013 - 09/2002
2
Thalidomide (Thalomid)
FDA Link
12/2012 - 01/2010
Therapy/Procedure
18
Drug Therapy (Chemotherapy)
11/2015 - 02/2002
10
Therapeutics
01/2015 - 07/2003
8
Heterologous Transplantation (Xenotransplantation)
06/2015 - 10/2007
5
Renal Dialysis (Hemodialysis)
05/2015 - 11/2007
4
Transplants (Transplant)
08/2013 - 01/2006
4
Immunotherapy
04/2012 - 09/2004
3
Aftercare (After-Treatment)
01/2009 - 02/2002
2
Hematopoietic Stem Cell Transplantation
11/2014 - 06/2014